Compounds > caffeine

caffeine and 2-hexynyladenosine-5'-n-ethylcarboxamide

caffeine has been researched along with 2-hexynyladenosine-5'-n-ethylcarboxamide in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arslan, G; Fredholm, BB; Kull, B; Lorenzen, A; Nilsson, C; Owman, C; Schwabe, U1
Belardinelli, L; Borea, PA; Merighi, S; Ongini, E; Portaluppi, F; Varani, K1
Belardinelli, L; Borea, PA; Gessi, S; Merighi, S; Ongini, E; Portaluppi, F; Varani, K1

Other Studies

3 other study(ies) available for caffeine and 2-hexynyladenosine-5'-n-ethylcarboxamide

ArticleYear
Differences in the order of potency for agonists but not antagonists at human and rat adenosine A2A receptors.
    Biochemical pharmacology, 1999, Jan-01, Volume: 57, Issue:1

    Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Binding, Competitive; CHO Cells; Cloning, Molecular; Cricetinae; Cyclic AMP; Humans; Kinetics; PC12 Cells; Phenethylamines; Polymerase Chain Reaction; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Pyrimidines; Radioligand Assay; Rats; Receptor, Adenosine A2A; Receptor, Adenosine A2B; Receptors, Purinergic P1; Recombinant Proteins; RNA, Messenger; Transcription, Genetic; Transfection; Triazoles; Tritium

1999
Caffeine alters A2A adenosine receptors and their function in human platelets.
    Circulation, 1999, May-18, Volume: 99, Issue:19

    Topics: Adenosine-5'-(N-ethylcarboxamide); Adult; Blood Platelets; Caffeine; Cyclic AMP; Female; Humans; Male; Middle Aged; Phosphodiesterase Inhibitors; Platelet Aggregation; Platelet Aggregation Inhibitors; Receptors, Purinergic P1; Signal Transduction

1999
Dose and time effects of caffeine intake on human platelet adenosine A(2A) receptors : functional and biochemical aspects.
    Circulation, 2000, Jul-18, Volume: 102, Issue:3

    Topics: Adenosine-5'-(N-ethylcarboxamide); Adult; Blood Platelets; Caffeine; Calcium; Cyclic AMP; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Myocardium; Platelet Aggregation; Platelet Aggregation Inhibitors; Purinergic P1 Receptor Agonists; Pyrimidines; Receptor, Adenosine A2A; Receptors, Purinergic P1; Time Factors; Triazoles; Up-Regulation

2000